Therefore, in lieu of these data, there may be common mechanisms between liver expressed APPs and peripheral inflammation in patients with ALS; APPs may differentiate disease burden and rates of disease progression in patients with ALS. Here, CTSB is linked to amyotrophic lateral sclerosis.